Patents-Review.com
🔗 Permalink
Assignee profile:

Allergan, Inc.

City:

Irvine, California

Country:

United States

Published Applications:

2,275

Last publication date:

2025-04-17

Patent Grants:

1,654

Last grant date:

2026-04-14

Allergan, Inc. is a global pharmaceutical company based in Irvine, US. It is a leading manufacturer of branded and generic drugs, as well as a provider of medical devices and services. Allergan's products are used to treat a variety of medical conditions, including eye care, central nervous system disorders, gastrointestinal disorders, and women's health. The company also has a strong presence in the aesthetics market, offering products such as Botox and Juvederm. Allergan is committed to providing innovative treatments to improve the lives of patients around the world.

Quarterly Allergan, Inc. Patent Applications

Top Inventors for applications by Allergan, Inc.

These are the the leading inventors for applications assigned to Allergan, Inc.:

Recent patent applications by Allergan, Inc.

Allergan, Inc. based in Irvine, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-04-17
US20250121169A1
Human necessities

DISSOLVABLE MICRONEEDLES FOR SKIN TEATMENT

 #2 | 2025-03-13 ✅ Patent 12,599,699 granted on 2026-04-14
US20250082820A1
Human necessities

CO-CROSSLINKED HYALURONIC ACID-SILK FIBROIN HYDROGELS FOR IMPROVING TISSUE GRAFT VIABILITY AND FOR SOFT TISSUE AUGMENTATION

 #3 | 2024-08-01 ✅ Patent 12,409,211 granted on 2025-09-09
US20240252604A1
Human necessities

NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS

 #4 | 2024-04-11 ✅ Patent 12,527,816 granted on 2026-01-20
US20240115599A1
Human necessities

SODIUM CHLORITE COMPOSITIONS WITH ENHANCED ANTI-MICROBIAL EFFICACY AND REDUCED TOXICITY

 #5 | 2024-02-15
US20240050726A1
Human necessities

MICRONEEDLE ARRAY WITH ACTIVE INGREDIENT

 #6 | 2024-02-01
US20240033492A1
Human necessities

DISSOLVABLE MICRONEEDLES FOR SKIN TREATMENT

 #7 | 2023-11-09 ✅ Patent 12,171,816 granted on 2024-12-24
US20230355724A1
Human necessities

Non-protein Clostridial toxin compositions

 #8 | 2023-11-09 ✅ Patent 12,144,847 granted on 2024-11-19
US20230355723A1
Human necessities

Non-protein clostridial toxin compositions

 #9 | 2023-10-12
US20230321420A1
Human necessities

MICRONEEDLE ARRAY WITH ACTIVE INGREDIENT

 #10 | 2023-01-26 ✅ Patent 12,241,098 granted on 2025-03-04
US20230029327A1
Chemistry; metallurgy

Process and system for obtaining botulinum neurotoxin

 #11 | 2022-10-20 ✅ Patent 11,524,075 granted on 2022-12-13
US20220331429A1
Human necessities

Animal protein-free pharmaceutical compositions

 #12 | 2022-09-22 ✅ Patent 11,530,400 granted on 2022-12-20
US20220298496A1
Chemistry; metallurgy

Process and system for obtaining botulinum neurotoxin

 #13 | 2022-07-21 ✅ Patent 11,518,986 granted on 2022-12-06
US20220228136A1
Chemistry; metallurgy

Process and system for obtaining botulinum neurotoxin

 #14 | 2022-05-12 ✅ Patent 11,525,130 granted on 2022-12-13
US20220145279A1
Chemistry; metallurgy

Process and system for obtaining botulinum neurotoxin

 #15 | 2022-02-03 ✅ Patent 11,326,155 granted on 2022-05-10
US20220033796A1
Chemistry; metallurgy

Process and system for obtaining botulinum neurotoxin

 #16 | 2022-01-27 ✅ Patent 12,004,995 granted on 2024-06-11
US20220023095A1
Human necessities

Intraocular implant with high loading of a prostamide

 #17 | 2021-11-11 ✅ Patent 11,285,216 granted on 2022-03-29
US20210346501A1
Human necessities

Animal protein-free pharmaceutical compositions

 #18 | 2021-11-04 ✅ Patent 11,332,518 granted on 2022-05-17
US20210340229A1
Chemistry; metallurgy

Immuno-based botulinum toxin serotype A activity assays

 #19 | 2021-11-04 ✅ Patent 11,738,043 granted on 2023-08-29
US20210338714A1
Human necessities

Sodium chlorite compositions with enhanced antimicrobial efficacy and reduced toxicity

 #20 | 2021-10-21 ✅ Patent 11,446,382 granted on 2022-09-20
US20210322553A1
Human necessities

Animal protein-free pharmaceutical compositions

 #21 | 2021-10-07
US20210307947A1
Human necessities

OVER MOLDED IMPLANTABLE DEVICE TO PROTECT TUBING FROM PUNCTURE

 #22 | 2021-09-23 ✅ Patent 11,203,748 granted on 2021-12-21
US20210292727A1
Chemistry; metallurgy

Process and system for obtaining botulinum neurotoxin

 #23 | 2021-09-02 ✅ Patent 11,147,878 granted on 2021-10-19
US20210268109A1
Human necessities

Animal protein-free pharmaceutical compositions

 #24 | 2021-06-17 ✅ Patent 11,286,234 granted on 2022-03-29
US20210179550A1
Chemistry; metallurgy

Phenyl urea derivatives as N-formyl peptide receptor modulators

 #25 | 2021-06-10 ✅ Patent 11,261,240 granted on 2022-03-01
US20210171614A1
Chemistry; metallurgy

Immuno-based botulinum toxin serotype A activity assays

 #26 | 2021-03-04 ✅ Patent 11,077,053 granted on 2021-08-03
US20210059930A1
Human necessities

Alpha-2-adrenergic receptor agonists for treatment of presbyopia, visual glare, visual starbursts, visual halos and night myopia

 #27 | 2021-02-11 ✅ Patent 11,033,625 granted on 2021-06-15
US20210038720A1
Human necessities

Method for stabilizing a toxin

 #28 | 2021-01-14 ✅ Patent 11,285,134 granted on 2022-03-29
US20210008034A1
Human necessities

Presbyopia treatments

 #29 | 2020-12-17 ✅ Patent 11,331,306 granted on 2022-05-17
US20200390747A1
Human necessities

Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases

 #30 | 2020-10-08 ✅ Patent 10,987,503 granted on 2021-04-27
US20200316356A1
Human necessities

Dissolvable microneedles for skin treatment

 #31 | 2020-08-06 ✅ Patent 10,799,518 granted on 2020-10-13
US20200246360A1
Human necessities

Use of agonists of formyl peptide receptor 2 for treating dermatological diseases

 #32 | 2020-07-30 ✅ Patent 11,202,853 granted on 2021-12-21
US20200237968A1
Human necessities

Porogen compositions, methods of making and uses

 #33 | 2020-07-09 ✅ Patent 10,988,474 granted on 2021-04-27
US20200216440A1
Chemistry; metallurgy

Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response

 #34 | 2020-06-18 ✅ Patent 11,890,457 granted on 2024-02-06
US20200188599A1
Human necessities

Aspiration and injection device

 #35 | 2020-06-04 ✅ Patent 10,765,629 granted on 2020-09-08
US20200170941A1
Human necessities

Solid complex, preparations and uses thereof

 #36 | 2020-04-23 ✅ Patent 11,028,163 granted on 2021-06-08
US20200123240A1
Chemistry; metallurgy

Heavy chain only antibodies to PDGF

 #37 | 2020-04-16 ✅ Patent 10,800,744 granted on 2020-10-13
US20200115346A1
Chemistry; metallurgy

Imidazole derivatives as formyl peptide receptor modulators

 #38 | 2020-04-16 ✅ Patent 11,497,598 granted on 2022-11-15
US20200113673A1
Human necessities

Lighter weight implant

 #39 | 2020-04-09 ✅ Patent 11,046,644 granted on 2021-06-29
US20200109110A1
Chemistry; metallurgy

Sulfur derivatives as chemokine receptor modulators

 #40 | 2020-04-02 ✅ Patent 12,208,155 granted on 2025-01-28
US20200101003A1
Human necessities

Method for improving duration of effect of dermal filler treatment

 #41 | 2020-03-19 ✅ Patent 11,160,630 granted on 2021-11-02
US20200085526A1
Human necessities

Tissue expansion device

 #42 | 2020-03-05 ✅ Patent 11,124,786 granted on 2021-09-21
US20200071686A1
Chemistry; metallurgy

Process and system for obtaining botulinum neurotoxin

 #43 | 2020-03-05 ✅ Patent 10,842,739 granted on 2020-11-24
US20200069578A1
Human necessities

Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof

 #44 | 2020-02-27 ✅ Patent 11,077,174 granted on 2021-08-03
US20200061164A1
Human necessities

Treatment of psychological trauma

 #45 | 2020-01-30 ✅ Patent 11,833,269 granted on 2023-12-05
US20200030490A1
Human necessities

Hyaluronic acid-collagen matrices for dermal filling and volumizing applications

 #46 | 2020-01-02 ✅ Patent 11,844,878 granted on 2023-12-19
US20200000968A1
Human necessities

Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation

 #47 | 2020-01-02 ✅ Patent 11,033,610 granted on 2021-06-15
US20200000892A1
Human necessities

Injection paradigm for administration of botulinum toxins

 #48 | 2019-12-19 ✅ Patent 11,083,685 granted on 2021-08-10
US20190381066A1
Human necessities

Methods for treating scars and aging skin

 #49 | 2019-11-21 ✅ Patent 11,684,719 granted on 2023-06-27
US20190351146A1
Human necessities

Methods of treatment using a syringe extrusion accessory

 #50 | 2019-11-21 ✅ Patent 10,973,890 granted on 2021-04-13
US20190351034A1
Human necessities

Non-protein clostridial toxin compositions

 #51 | 2019-11-14 ✅ Patent 10,993,931 granted on 2021-05-04
US20190343804A1
Human necessities

Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

 #52 | 2019-10-31 ✅ Patent 11,096,958 granted on 2021-08-24
US20190328773A1
Human necessities

Sodium chlorite compositions with enhanced anti-microbial efficacy and reduced toxicity

 #53 | 2019-10-24 ✅ Patent 10,900,967 granted on 2021-01-26
US20190324041A1
Physics

Immuno-based retargeted endopeptidase activity assays

 #54 | 2019-10-24 ✅ Patent 10,610,518 granted on 2020-04-07
US20190321337A1
Human necessities

Presbyopia treatments

 #55 | 2019-10-10 ✅ Patent 11,248,219 granted on 2022-02-15
US20190309277A1
Chemistry; metallurgy

Fusion proteins comprising a non-cytotoxic protease, a translocation domain, and a targeting moiety that binds a galanin receptor and methods for treating, preventing or ameliorating pain using such fusion proteins

 #56 | 2019-10-10 ✅ Patent 10,864,218 granted on 2020-12-15
US20190307769A1
Human necessities

Hypotensive lipid-containing biodegradable intraocular implants and related methods

 #57 | 2019-10-10 ✅ Patent 10,792,288 granted on 2020-10-06
US20190307759A1
Human necessities

Preservative free brimonidine and timolol solutions

 #58 | 2019-08-22 ✅ Patent 10,744,227 granted on 2020-08-18
US20190255215A1
Human necessities

Co-crosslinked hyaluronic acid-silk fibroin hydrogels for improving tissue graft viability and for soft tissue augmentation

 #59 | 2019-08-22 ✅ Patent 10,874,605 granted on 2020-12-29
US20190254964A1
Human necessities

Extended release biodegradable ocular implants

 #60 | 2019-08-15 ✅ Patent 11,046,756 granted on 2021-06-29
US20190248882A1
Chemistry; metallurgy

Heavy chain only antibodies to ANG-2

 #61 | 2019-08-15
US20190247476A1
Human necessities

NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS

 #62 | 2019-08-08 ✅ Patent 10,874,722 granted on 2020-12-29
US20190240299A1
Human necessities

Suture line administration technique using botulinum toxins

 #63 | 2019-08-08 ✅ Patent 10,555,933 granted on 2020-02-11
US20190240200A1
Human necessities

Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases

 #64 | 2019-07-11 ✅ Patent 11,992,668 granted on 2024-05-28
US20190209789A1
Human necessities

Injection device

 #65 | 2019-07-04 ✅ Patent 11,185,641 granted on 2021-11-30
US20190201635A1
Human necessities

Devices for injection and dosing

 #66 | 2019-05-23 ✅ Patent 10,899,780 granted on 2021-01-26
US20190153004A1
Chemistry; metallurgy

Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases

 #67 | 2019-05-02 ✅ Patent 11,117,860 granted on 2021-09-14
US20190127319A1
Chemistry; metallurgy

Phenyl urea derivatives as n-formyl peptide receptor modulators

 #68 | 2019-04-25 ✅ Patent 10,501,483 granted on 2019-12-10
US20190119304A1
Chemistry; metallurgy

Enamines and diastereo-selective reduction of enamines

 #69 | 2019-03-07 ✅ Patent 10,604,563 granted on 2020-03-31
US20190071492A1
Chemistry; metallurgy

Nucleic acids encoding anti-complement Factor Bb antibodies

 #70 | 2019-02-28 ✅ Patent 10,729,751 granted on 2020-08-04
US20190060423A1
Human necessities

Injection paradigm for administration of botulinum toxins

 #71 | 2019-02-14 ✅ Patent 11,208,377 granted on 2021-12-28
US20190047947A1
Chemistry; metallurgy

3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof

 #72 | 2019-02-14 ✅ Patent 10,905,797 granted on 2021-02-02
US20190046687A1
Human necessities

Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation

 #73 | 2019-02-07 ✅ Patent 11,078,085 granted on 2021-08-03
US20190039911A1
Chemistry; metallurgy

Production of rounded salt particles

 #74 | 2019-02-07 ✅ Patent 10,603,366 granted on 2020-03-31
US20190038726A1
Human necessities

Methods for treating headache

 #75 | 2019-02-07 ✅ Patent 10,881,608 granted on 2021-01-05
US20190038551A1
Human necessities

Biodegradable intravitreal tyrosine kinase implants

 #76 | 2019-01-31 ✅ Patent 10,350,055 granted on 2019-07-16
US20190029807A1
Human necessities

Textured breast implant and methods of making same

 #77 | 2019-01-17 ✅ Patent 10,524,897 granted on 2020-01-07
US20190015196A1
Human necessities

Lighter weight implant

 #78 | 2019-01-17 ✅ Patent 10,765,506 granted on 2020-09-08
US20190015195A1
Human necessities

Inflatable prostheses and methods of making same

 #79 | 2018-12-27 ✅ Patent 10,888,598 granted on 2021-01-12
US20180369311A1
Human necessities

Efficient lipid delivery to human tear film using a salt-sensitive emulsion system

 #80 | 2018-12-13 ✅ Patent 10,471,004 granted on 2019-11-12
US20180353426A1
Human necessities

Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof

 #81 | 2018-12-06 ✅ Patent 10,912,823 granted on 2021-02-09
US20180344820A1
Human necessities

Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin

 #82 | 2018-11-15 ✅ Patent 10,610,565 granted on 2020-04-07
US20180325996A1
Human necessities

Prevention and treatment of ocular side effects with a cyclosporin

 #83 | 2018-10-25 ✅ Patent 10,792,427 granted on 2020-10-06
US20180304013A1
Human necessities

High force injection devices

 #84 | 2018-10-25 ✅ Patent 10,758,470 granted on 2020-09-01
US20180303742A1
Human necessities

Cross linked silk-hyaluronic acid composition

 #85 | 2018-10-04 ✅ Patent 10,709,545 granted on 2020-07-14
US20180280131A1
Human necessities

Implantable prostheses for tissue expansion

 #86 | 2018-09-20 ✅ Patent 11,045,515 granted on 2021-06-29
US20180264063A1
Human necessities

Artificial tears and therapeutic uses

 #87 | 2018-08-23 ✅ Patent 11,065,428 granted on 2021-07-20
US20180236215A1
Human necessities

Microneedle array with active ingredient

 #88 | 2018-08-16 ✅ Patent 10,603,477 granted on 2020-03-31
US20180229017A1
Human necessities

Dissolvable microneedles for skin treatment

 #89 | 2018-08-16 ✅ Patent 10,661,022 granted on 2020-05-26
US20180228982A1
Human necessities

Substance delivery device

 #90 | 2018-08-16 ✅ Patent 10,172,832 granted on 2019-01-08
US20180228772A1
Human necessities

Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

 #91 | 2018-08-09 ✅ Patent 10,752,678 granted on 2020-08-25
US20180222969A1
Chemistry; metallurgy

Complement component C5 antibodies

 #92 | 2018-08-09 ✅ Patent 10,780,098 granted on 2020-09-22
US20180221388A1
Human necessities

Non-irritating testosterone emulsions

 #93 | 2018-07-26 ✅ Patent 10,328,086 granted on 2019-06-25
US20180207174A1
Human necessities

Hypotensive lipid-containing biodegradable intraocular implants and related methods

 #94 | 2018-07-19 ✅ Patent 10,675,144 granted on 2020-06-09
US20180200045A1
Human necessities

Soft filled prosthesis shell with discrete fixation surfaces

 #95 | 2018-07-05 ✅ Patent 10,420,823 granted on 2019-09-24
US20180185460A1
Human necessities

Method for treating premature ejaculation with a botulinum neurotoxin

 #96 | 2018-07-05 ✅ Patent 10,058,560 granted on 2018-08-28
US20180185385A1
Human necessities

Preservative free bimatoprost and timolol solutions

 #97 | 2018-06-21 ✅ Patent 10,407,382 granted on 2019-09-10
US20180170858A1
Chemistry; metallurgy

EPagonists as therapeutic compounds

 #98 | 2018-06-21 ✅ Patent 10,702,515 granted on 2020-07-07
US20180169086A1
Human necessities

Compositions containing aromatic aldehydes and their use in treatments

 #99 | 2018-06-14 ✅ Patent 10,668,081 granted on 2020-06-02
US20180161342A1
Human necessities

Prostamide-containing intraocular implant

 #100 | 2018-06-07 ✅ Patent 10,064,872 granted on 2018-09-04
US20180153903A1
Human necessities

Oil-in-water method for making polymeric implants containing a hypotensive lipid

Also check out ALLERGAN, INC.'s (Irvine, United States) applicant profile with 648 patent applications submitted.

AssigneeID:

1935 ⎘